Catalyst Wire Dossier Catalyst Wire Dossier

Veyvondi

vonicog alfa · Baxalta Innovations GmbH
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Veyvondi, covering 2026-01-20 to 2026-07-15. Get the full timeline:

Most recent: EMA Authorised: Veyvondi (vonicog alfa) — Baxalta Innovations GmbH

See pricing